PTJ
TNDM icon

Paul Tudor Jones’s Tandem Diabetes Care TNDM Stock Holding History

Paul Tudor Jones’s Portfolio TNDM Stock Details TNDM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.47M Buy
362,708
+283,709
+359% +$4.95M 0.01% 1225
2026
Q1 		$1.51M Sell
78,999
-29,064
-27% -$632K ﹤0.01% 2062
2025
Q4 		$2.38M Buy
+108,063
New +$1.95M ﹤0.01% 1693
2025
Q3 		– Sell
-311,517
Closed -$4.22M – 3893
2025
Q2 		$5.81M Sell
311,517
-93,775
-23% -$1.86M 0.01% 1008
2025
Q1 		$7.77M Buy
405,292
+236,249
+140% +$6.91M 0.03% 581
2024
Q4 		$6.09M Buy
169,043
+128,294
+315% +$4.34M 0.02% 590
2024
Q3 		$1.73M Sell
40,749
-24,477
-38% -$1.04M 0.01% 1291
2024
Q2 		$2.63M Sell
65,226
-12,109
-16% -$505K 0.01% 929
2024
Q1 		$2.74M Sell
77,335
-154,403
-67% -$4.14M 0.02% 877
2023
Q4 		$6.85M Buy
231,738
+16,356
+8% +$339K 0.06% 488
2023
Q3 		$4.47M Buy
215,382
+8,292
+4% +$228K 0.04% 538
2023
Q2 		$5.08M Buy
207,090
+136,914
+195% +$4.4M 0.06% 424
2023
Q1 		$2.85M Buy
+70,176
New +$2.91M 0.04% 610
2022
Q4 		– Sell
-7,408
Closed -$354K – 2852
2022
Q3 		$354K Sell
7,408
-13,761
-65% -$754K 0.01% 1665
2022
Q2 		$1.25M Buy
+21,169
New +$1.74M 0.03% 752
2022
Q1 		– Sell
-29,551
Closed -$4.45M – 2673
2021
Q4 		$4.45M Buy
+29,551
New +$3.99M 0.07% 301
2021
Q3 		– Sell
-13,148
Closed -$1.28M – 2802
2021
Q2 		$1.28M Buy
13,148
+5,929
+82% +$529K 0.02% 751
2021
Q1 		$637K Buy
+7,219
New +$671K 0.01% 1046
2019
Q3 		– Sell
-49,724
Closed -$3.21M – 1340
2019
Q2 		$3.21M Buy
49,724
+31,917
+179% +$2.06M 0.09% 188
2019
Q1 		$1.13M Buy
+17,807
New +$935K 0.05% 433
2014
Q1 		– Sell
-1,930
Closed -$497K – 1407
2013
Q4 		$497K Buy
+1,930
New +$442K 0.02% 559

Other funds holding TNDM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SC
Sessa Capital New York $5.98B AUM 99.85% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
GKIM
GW&K Investment Management Boston, Massachusetts $12.8B AUM 48.82% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
PIM
Paradice Investment Management Denver, Colorado $627M AUM 43.41% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $27.8B AUM 46.46% 1-Year Est. Return

Paul Tudor Jones's TNDM Position: Q2 2026 in Review

Paul Tudor Jones increased its Tandem Diabetes Care (TNDM) stake by 359% in Q2 2026, buying an estimated $4.95M and bringing the position to 362,708 shares worth $5.47M. The position accounts for 0.01% of the portfolio, ranked #1225.

Paul Tudor Jones first reported a position in TNDM in Q4 2013 and has held it in 21 quarters since. The position peaked at $7.77M in Q1 2025. 272 funds tracked by Wall St. Rank hold TNDM as of Q2 2026.

  • Paul Tudor Jones held 362,708 shares of Tandem Diabetes Care worth $5.47M as of Q2 2026.
  • Paul Tudor Jones bought 283,709 Tandem Diabetes Care shares in Q2 2026, an estimated $4.95M.
  • Tandem Diabetes Care made up 0.01% of Paul Tudor Jones's portfolio in Q2 2026, its #1225 holding.
  • Paul Tudor Jones first reported a position in Tandem Diabetes Care in Q4 2013 and has held it in 21 quarters since.
  • Paul Tudor Jones's Tandem Diabetes Care position peaked at $7.77M in Q1 2025.
  • 272 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q2 2026.

Based on Tudor Investment Corp's 13F filing for Q2 2026, filed 14 Aug 2026.